Megan D. Bailey - 01 May 2023 Form 3 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, Chief Strategy Officer
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Megan D. Bailey
Issuer symbol
LH
Transactions as of
01 May 2023
Net transactions value
$0
Form type
3
Filing time
08 May 2023, 15:21:04 UTC
Next filing
09 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LH Common Stock 122 01 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LH Restricted Stock Unit 01 May 2023 Common Stock 367 Direct F1, F2
holding LH Restricted Stock Unit 01 May 2023 Common Stock 600 Direct F2, F3
holding LH Restricted Stock Unit 01 May 2023 Common Stock 3,660 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units vest in two equal installments on April 1, 2024 and April 1, 2025.
F2 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F3 The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024.
F4 The Restricted Stock Units vest on April 1, 2025.

Remarks:

Exhibit 24 - Power of Attorney